YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Declares $0.00 Dividend

Posted by Mark Dietrich on Dec 30th, 2025

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report) declared a dividend on Monday, December 29th. Stockholders of record on Tuesday, December 30th will be given a dividend of 0.0002 per share on Wednesday, December 31st. This represents a dividend yield of 6.0%. The ex-dividend date of this dividend is Tuesday, December 30th.

YieldMax MRNA Option Income Strategy ETF Stock Performance

MRNY opened at $15.43 on Tuesday. The firm’s 50-day moving average price is $15.59 and its 200-day moving average price is $18.85. YieldMax MRNA Option Income Strategy ETF has a 52-week low of $13.60 and a 52-week high of $56.65.

Institutional Investors Weigh In On YieldMax MRNA Option Income Strategy ETF

A hedge fund recently raised its stake in YieldMax MRNA Option Income Strategy ETF stock. OLD Mission Capital LLC increased its stake in shares of YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Free Report) by 235.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,034 shares of the company’s stock after buying an additional 69,476 shares during the quarter. OLD Mission Capital LLC owned about 0.34% of YieldMax MRNA Option Income Strategy ETF worth $273,000 as of its most recent SEC filing.

About YieldMax MRNA Option Income Strategy ETF

(Get Free Report)

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.